<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epidemiological data show that the incidence of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is a least 4-5 times as high in the far East as in the West </plain></SENT>
<SENT sid="1" pm="."><plain>The reason seems to be complex--a number of exogenic factors act against a background of genetic differences in susceptibility </plain></SENT>
<SENT sid="2" pm="."><plain>A Swedish study of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> shows the overall incidence to be 13 cases per million inhabitants and year, but also that the incidence varies greatly with age (range 4-61 cases per million) </plain></SENT>
<SENT sid="3" pm="."><plain>Drugs are the single most important aetiologic factor </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="17698">Chloramphenicol</z:chebi> is the most common offender, but in many countries it now has been replaced by the <z:chebi fb="1" ids="35472">anti-inflammatory agents</z:chebi> phenylbutazone and oxyphenbutazone </plain></SENT>
<SENT sid="5" pm="."><plain>In Sweden the latter also have disappeared and <z:chebi fb="0" ids="35358">sulfonamide</z:chebi> preparations dominate among drugs causing <z:mpath ids='MPATH_58'>aplasia</z:mpath> </plain></SENT>
</text></document>